Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
APLS
APLS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
APLS News
Biogen Completes Acquisition of Apellis Pharmaceuticals
May 14 2026
Globenewswire
Biogen Completes Acquisition of Apellis Pharmaceuticals
May 14 2026
Newsfilter
S&P Dow Jones Indices: Bright Horizons Family Solutions and Remitly Global to be Added to S&P SmallCap 600
May 07 2026
moomoo
Analysis of XBI ETF Trading Dynamics
May 06 2026
NASDAQ.COM
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
May 05 2026
Globenewswire
Monteverde Law Firm Investigates Multiple Acquisition Cases
May 05 2026
Globenewswire
Biogen Reports Earnings Beat, Shares Surge 6%
Apr 30 2026
Fool
Market Preview: Tech Giants Earnings Day
Apr 29 2026
CNBC
Investor Rights Law Firm Investigates Multiple Companies
Apr 20 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
Apr 14 2026
PRnewswire
Biogen Shares Rise After Upgrade and Acquisition Announcement
Apr 14 2026
seekingalpha
Investor Rights Law Firm Investigates Multiple Companies
Apr 10 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
Apr 07 2026
PRnewswire
Monteverde Law Firm Investigates Multiple Acquisition Cases
Apr 07 2026
Globenewswire
Ademi LLP Investigates Apellis for Potential Fiduciary Breaches in Biogen Deal
Apr 07 2026
Globenewswire
Biogen Plans $34 Million Charge Impacting Q1 Earnings
Apr 07 2026
Fool
Show More News
